Company Performance Metrics
- Michael Crapanzano: Founder and CEO
- Tee Bordelon: CSO
LigaTrap has developed a novel, patented portfolio of affinity ligands for the purification of monoclonal and polyclonal immunoglobulins from various species. In addition to species-specific ligands, advantages include the ability to elute bound antibodies at a milder pH (pH 4.0) than proteins A and G (pH ≤ 3.0), thus reducing the potential for
precipitation and inactivation of pH sensitive antibodies.
Their research lab is in Raleigh, NC and their corporate office is in Baton Rouge, LA, their goal is to generate high purity antibodies using ligands superior to those currently available in the marketplace. Through extensive side-by-side testing with purification products that are currently on the market, beta testing from independent third parties, market research by industry experts, and feedback from leading think tanks within the sector, the technology is proven and deemed superior to those available in specific niche uses.
